Coloplast A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0060448595
DKK
581.20
433.64 (293.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
No of Months
12
12
12
12
12
12
Operating Income
27,030.00
24,500.00
22,579.00
19,426.00
18,544.00
17,939.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
27,030.00
24,500.00
22,579.00
19,426.00
18,544.00
17,939.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
8,761.00
7,448.00
6,786.00
5,613.00
5,439.00
5,285.00
Operating Expenses
882.00
719.00
240.00
57.00
63.00
54.00
General and Administration Expenses
9,332.00
8,024.00
7,306.00
5,960.00
5,761.00
5,829.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
19,743.00
17,677.00
15,718.00
13,130.00
12,738.00
12,416.00
Operating Profit (PBDIT) excl Other Income
7,287.00
6,823.00
6,861.00
6,296.00
5,806.00
5,523.00
Other Income
-44.00
-12.00
191.00
204.00
-187.00
2.00
Operating Profit (PBDIT)
8,656.00
7,846.00
7,957.00
7,263.00
6,470.00
6,176.00
Interest
882.00
719.00
240.00
57.00
63.00
54.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
1,290.00
1,069.00
930.00
792.00
851.00
651.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
6,395.00
6,025.00
6,127.00
6,233.00
5,466.00
5,028.00
Provision for Tax
1,343.00
1,242.00
1,421.00
1,408.00
1,269.00
1,155.00
Profit After Tax
5,052.00
4,783.00
4,706.00
4,825.00
4,197.00
3,873.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
22.46
22.19
22.11
22.63
19.68
18.17
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is 10.33% vs 8.51% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is 6.80% vs -0.55% in Sep 2023

stock-summary

Interest

YoY Growth in year ended Sep 2024 is 22.67% vs 199.58% in Sep 2023

stock-summary

Profit After Tax

YoY Growth in year ended Sep 2024 is 5.62% vs 1.64% in Sep 2023

Compare Profit and Loss Results of Coloplast A/S
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
No of Months
12
12
Operating Income
27,030.00
22,424.00
4,606.00
20.54%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
27,030.00
22,424.00
4,606.00
20.54%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
8,761.00
9,555.00
-794.00
-8.31%
Operating Expenses
882.00
652.00
230.00
35.28%
General and Administration Expenses
9,332.00
9,733.00
-401.00
-4.12%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19,743.00
17,711.00
2,032.00
11.47%
Operating Profit (PBDIT) excl Other Income
7,287.00
4,713.00
2,574.00
54.61%
Other Income
-44.00
387.00
-431.00
-111.37%
Operating Profit (PBDIT)
8,656.00
6,535.00
2,121.00
32.46%
Interest
882.00
652.00
230.00
35.28%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
1,290.00
1,435.00
-145.00
-10.10%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6,395.00
3,617.00
2,778.00
76.80%
Provision for Tax
1,343.00
824.00
519.00
62.99%
Profit After Tax
5,052.00
2,891.00
2,161.00
74.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
22.4633
11.104
11.36
102.30%
Profit And Loss - Net Sales
Net Sales 27,030.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 10.33% vs 8.51% in Sep 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7,287.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 6.80% vs -0.55% in Sep 2023

Profit And Loss - Interest
Interest 882.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 22.67% vs 199.58% in Sep 2023

Profit And Loss - Profit After Tax
Profit After Tax 5,052.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 5.62% vs 1.64% in Sep 2023